cafead's Recent Activity
-
cafead posted a new thread.
FDA mandates label updates on CAR-T cancer therapies
via The U.S. Food and Drug Administration said on Thursday cancer therapies that use CAR-T technology will require changes to the...
Forum: Pharma/Biotech Companies - In the News
Apr 18, 2024 at 10:42 PM -
cafead posted a new thread.
Sanofi, busy with cost-savings campaign, restructures US commercial vaccine group
via During a busy period of overhaul at Sanofi, the company is restructuring its U.S. vaccine commercial group. The company is...
Forum: Pharma/Biotech Companies - In the News
Apr 18, 2024 at 10:42 PM -
cafead posted a new thread.
Roche’s Early Alzheimer’s Blood Test Gets FDA Breakthrough Device Designation
via Roche has received Breakthrough Device designation from the US Food and Drug Administration (FDA) for its Elecsys pTau217 early...
Forum: Pharma/Biotech Companies - In the News
Apr 18, 2024 at 10:42 PM -
cafead posted a new thread.
Drugs Like Ozempic And Mounjaro Could Treat Other Conditions—Here’s What Scientists Are...
via Weight loss and diabetes may just be the beginning for drugs like Ozempic, Wegovy, Mounjaro and Zepbound as reports increasingly...
Forum: Pharma/Biotech Companies - In the News
Apr 18, 2024 at 10:42 PM -
cafead posted a new thread.
Intra-Cellular Looks to Raise $500M in Public Offering Following Phase III MDD Win
via Following a victory in a late-stage major depressive disorder trial, Intra-Cellular Therapies is out to raise capital. The biopharma...
Forum: Pharma/Biotech Companies - In the News
Apr 18, 2024 at 10:42 PM -
cafead posted a new thread.
Amgen CEO nabs pay raise thanks to Horizon deal. Does that incentivize aggressive M&A?
via Amgen CEO Robert Bradway scored a 5.8% increase in overall compensation last year mostly thanks to the company’s acquisition of...
Forum: Pharma/Biotech Companies - In the News
Apr 18, 2024 at 10:22 PM -
cafead posted a new thread.
AI Identifies New Potential Treatments For Parkinson’s Disease
via A new artificial intelligence (AI) based strategy has significantly sped up the identification of potential new drugs to treat...
Forum: Pharma/Biotech Companies - In the News
Apr 18, 2024 at 11:52 AM -
cafead posted a new thread.
23andMe Jumps as CEO Floats Taking DNA Tester Private
via DNA testing firm 23andMe Holding Co.’s shares soared after Chief Executive Officer Anne Wojcicki said she’s considering taking the...
Forum: Pharma/Biotech Companies - In the News
Apr 18, 2024 at 11:32 AM -
cafead posted a new thread.
Pharma goes urban: The rise of city manufacturing facilities
via When imagining a pharmaceutical manufacturing facility, many picture it in a vast rural setting, offering ample space for...
Forum: Pharma/Biotech Companies - In the News
Apr 18, 2024 at 11:32 AM -
cafead posted a new thread.
AbbVie touts Rinvoq win in giant cell arteritis, potentially teeing up another label expansion
via On Thursday, AbbVie said that Rinvoq, also known as upadacitinib, met its primary endpoint in the SELECT-GCA trial in patients with...
Forum: Pharma/Biotech Companies - In the News
Apr 18, 2024 at 11:32 AM -
cafead posted a new thread.
FDA fast-tracks AskBio’s heart failure gene therapy
via A gene therapy for heart failure being developed by Bayer’s AskBio unit has been granted fast-track status by the FDA, shortly after...
Forum: Pharma/Biotech Companies - In the News
Apr 18, 2024 at 11:32 AM -
cafead posted a new thread.
UK drug shortages swell amid Brexit supply woes, think-tank data shows
via Drug shortages in the UK more than doubled between 2020 and 2023 with Brexit likely to "significantly weaken" the country's ability...
Forum: Pharma/Biotech Companies - In the News
Apr 18, 2024 at 11:32 AM -
cafead posted a new thread.
Biopharma M&A more than doubled in the first quarter compared to the year prior: report
via The number of biopharma M&A deals more than doubled in the first quarter of 2024 compared to the same period a year ago,...
Forum: Pharma/Biotech Companies - In the News
Apr 18, 2024 at 11:12 AM -
cafead posted a new thread.
Vertex inches closer to acute pain market with FDA application acceptance
via Vertex Pharmaceuticals has inched closer to bringing a new, non-opioid med to the blockbuster pain market, with the FDA accepting a...
Forum: Pharma/Biotech Companies - In the News
Apr 18, 2024 at 11:12 AM -
cafead posted a new thread.
Cerevel, in ‘major surprise,’ finds success in late-stage Parkinson’s study
via Analysts hadn’t been expecting positive results from the trial of Cerevel’s drug tavapadon, but data showed it helped improve...
Forum: Pharma/Biotech Companies - In the News
Apr 18, 2024 at 11:12 AM